Skip to main content
Bavarian Nordic logo

Bavarian Nordic — Investor Relations & Filings

Ticker · BAVA ISIN · DK0015998017 LEI · 2138006JCDVYIN6INP51 CO Manufacturing
Open in API
Filings indexed 2,297 across all filing types
Latest filing 2025-06-18 Share Issue/Capital Cha…
Country DK Denmark
Listing CO BAVA

About Bavarian Nordic

https://www.bavarian-nordic.com/

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Recent filings

Filing Released Lang Actions
Share Issue/Capital Change 2025
Share Issue/Capital Change Classification · 99% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and details a specific corporate transaction: the sale of a Priority Review Voucher (PRV) for USD 160 million. It includes key financial impacts (revenue, EBITDA), closing conditions, and is dated June 18, 2025. This type of announcement, which communicates a significant, non-periodic corporate event or transaction (like a financing deal or asset sale), fits best under Capital/Financing Update (CAP) or, given its nature as a general regulatory disclosure in Danish markets, potentially Regulatory Filings (RNS). Since the sale of a voucher is a specific financing/capital event, CAP is a strong candidate. However, the text is a formal, brief announcement of a material event, which often falls under general regulatory disclosure if a more specific category like M&A (TAR) or Share Issue (SHA) doesn't apply. The sale of a voucher is a form of capital realization/financing activity. Given the options, 'CAP' (Capital/Financing Update) is the most precise fit for announcing the sale of a valuable asset/voucher that impacts financing and EBITDA outlook. It is not an Earnings Release (ER), Interim Report (IR), or a standard 10-K/AR. It is a specific, material corporate action announcement.
2025-06-18 Danish
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is explicitly titled "Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such." It details the acquisition of shares via the vesting of restricted stock units (RSUs) by board members and executives, citing compliance with Article 19 of Regulation No. 596/2014 (Market Abuse Regulation). This type of mandatory disclosure concerning insider transactions by management is specifically categorized as Director's Dealing (DIRS).
2025-05-09 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is titled "Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer" (Reporting of transactions in Bavarian Nordic shares and related securities by key employees and persons closely associated with them). It explicitly references EU Regulation No 596/2014 (§19) and details share transactions (overdragelse af Restricted Stock Units - RSU transfers) by board members and senior management (Anne Louise Eberhard, Frank Verwiel, Anja Gjøl, Paul Chaplin, Russell Thirsk). This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors).
2025-05-09 Danish
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document explicitly reports on 'transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities' (insider transactions). It details acquisitions of shares due to the vesting of Restricted Stock Units (RSUs) by the Board of Directors and Executive Management, citing compliance with Article 19 of Regulation No. 596/2014 (Market Abuse Regulation). This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors).
2025-05-09 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is titled "Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer" (Reporting of transactions by management personnel and their closely associated persons in Bavarian Nordic shares and related securities). It explicitly details share transactions (overdragelse af Restricted Stock Units - RSU transfers) made by directors and senior management (Anne Louise Eberhard, Frank Verwiel, Paul Chaplin, Russell Thirsk, etc.). This directly corresponds to the definition of Director's Dealing (insider trades). The document cites EU regulations (§19 of Regulation (EU) No 596/2014), confirming its regulatory nature regarding insider transactions. The classification code DIRS (Director's Dealing) is the most appropriate fit.
2025-05-09 Danish
Regulatory Filings 2025
Regulatory Filings Classification · 100% confidence The document is a press release written in Danish announcing that Bavarian Nordic has been awarded contract options by the US government (BARDA/HHS) for the production and delivery of a freeze-dried smallpox and mpox vaccine (JYNNEOS®). It details the value of the options (USD 143.6 million), confirms that the company's 2025 financial guidance remains unchanged, and provides background on the contract history. This type of announcement, detailing a significant business event, contract award, or financial update outside of a standard periodic report (like 10-K or IR), is typically classified as an Earnings Release (ER) if it contains key financial highlights, or a Regulatory Filing (RNS) if it's a general announcement. Since it explicitly mentions financial guidance updates and is a material event announcement, it strongly aligns with the function of an Earnings Release (ER) or a significant corporate announcement. Given the specific nature of the announcement (contract award with financial implications), and the lack of a specific code for 'Contract Award', ER is the closest fit for a material, time-sensitive financial/operational update. However, since it is not explicitly an 'Earnings Release' detailing quarterly results, and it is a general corporate announcement, RNS (Regulatory Filings - the fallback for miscellaneous filings) is also a strong candidate. Reviewing the definitions, ER is for 'Initial announcement of quarterly/periodical financial results (key highlights only)'. This is a contract award announcement that *includes* financial guidance confirmation. Given the context of material corporate news that isn't a standard report, RNS is the most appropriate general regulatory filing category, although ER captures the financial update aspect. I will lean towards RNS as the most accurate fallback for a material, non-periodic corporate announcement that doesn't fit the specific report types (like 10-K, IR, or ER which is usually tied to quarterly results). The document length is substantial (6672 chars), so it is not an RPA. I will classify it as RNS as it is a general regulatory announcement regarding a significant contract.
2025-05-06 Danish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.